SFPIM
FPIM is a private equity firm that invests in aviation and real estate sectors.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed SFPIM Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
9,067,321Website Global Rank
217Website Monthly Traffic
Twitter Followers
Description
FPIM is a private equity firm that invests in aviation and real estate sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2022 | Univercells | Series D | 0 |
| 11/2014 | Promethera Biosciences | Series C | 0 |
| 1/2021 | Endo Tools Therapeutics | Series D | 0 |
| 12/2016 | PDC*line Pharma | Series A | 4.3M |
| 6/2014 | IBA | Venture Round | 27.4M |
| 9/2019 | iSTAR Medical | Series C | 44.1M |
| 3/2018 | Air Belgium | Venture Round | 24.6M |
| 3/2017 | Ncardia | Venture Round | 2.7M |
| 2/2021 | Imcyse | Series B | 25.7M |
| 12/2020 | Univercells | Series C | 24.5M |
| 12/2021 | PDC*line Pharma | Series B | 0 |
| 6/2019 | Imcyse | Series B | 31.4M |
| 2/2019 | Endo Tools Therapeutics | Series C | 5.6M |
| 10/2013 | NovoPolymers | Private Equity Round | - |
| 12/2022 | Tangent Works | Series A | 4.3M |
| 5/2012 | ITeos Therapeutics | Series A | 11.8M |
| 12/2021 | EyeD Pharma | Venture Round | 0 |
| 1/2018 | Miracor Medical | Series D | 0 |
| 9/2018 | Miracor Medical | Series D | 0 |
| 7/2021 | Itsme | Venture Round | 0 |
| 3/2012 | NovoPolymers | Venture Round | 7.1M |
| 8/2022 | Magnax | Venture Round | 19.9M |
| 10/2022 | Axelera AI | Series A | 27M |
| 4/2020 | ITeos Therapeutics | Series B | 0 |
| 11/2022 | Cohabs | Series C | 0 |
| 10/2018 | Sequana Medical | Series D | 0 |
| 9/2020 | Miracor Medical | Series E | 0 |
| 1/2018 | PharmaFluidics | Venture Round | 0 |
| 4/2016 | iSTAR Medical | Series B | 11.4M |
| 7/2015 | NovoPolymers | Venture Round | - |
| 6/2018 | ITeos Therapeutics | Series B | 0 |
| 8/2019 | Ninepointfive | Funding Round | 27.7M |
| 2/2018 | Synergia Medical | Series A | 10M |
| 2/2020 | OncoDNA | Series B | 0 |
| 7/2019 | Unifly | Series B | 0 |
| 7/2020 | ExeVir Bio | Series A | 0 |
| 11/2017 | Ncardia | Series B | 12.4M |
| 12/2021 | EyeD Pharma | Venture Round | 0 |
| 12/2021 | PDC*line Pharma | Series B | 0 |
| 7/2021 | Itsme | Venture Round | 0 |
| 2/2021 | Imcyse | Series B | 0 |
| 1/2021 | Endo Tools Therapeutics | Series D | 0 |
| 12/2020 | Univercells | Series C | 0 |
| 9/2020 | Miracor Medical | Series E | 0 |
| 7/2020 | ExeVir Bio | Series A | 0 |
| 4/2020 | ITeos Therapeutics | Series B | 0 |
| 2/2020 | OncoDNA | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
